
News|Articles|December 16, 2025
A look into the volume of Quest lab data for breast cancer research
Author(s)Quest Diagnostics
This datasheet illustrates how Quest Diagnostics' extensive de-identified lab data can be leveraged to accelerate and optimize clinical trials for breast cancer research. Researchers can use this real-world data to identify high concentrations of eligible patients, select optimal trial sites, find suitable principal investigators, and drive targeted patient recruitment efforts.
Trending on Applied Clinical Trials Online
1
Applying Systems Thinking to the Future of Clinical R&D
2
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
3
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
4
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
5